Morphosys AG (MPSYY)


Other OTC - Other OTC Delayed Price. Currency in USD
21.35-0.54 (-2.48%)
At close: 11:24 AM EDT
People also watch:
MKGAYGEAGYMAGOYHENKYMURGY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open21.43
Prev Close21.89
Bid0.00 x
Ask0.00 x
Day's Range21.35 - 21.67
52wk Range21.35 - 21.67
1y Target EstN/A
Market Cap1.12B
P/E Ratio (ttm)-24.26
Beta0.74
Volume4,334
Avg Vol (3m)4,300
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • MorphoSys AG :MPSYY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
    Capital Cube20 days ago

    MorphoSys AG :MPSYY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016

    Categories: Yahoo Finance Click here to see latest analysis MorphoSys AG reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of MorphoSys AG – Quest Diagnostics Incorporated, Merck & Co., Inc., Johnson & Johnson, Novartis AG Sponsored ADR, PDL BioPharma, Inc., Rockwell Collins, Inc., STADA Arzneimittel AG Unsponsored ... Read more (Read more...)

  • MorphoSys AG :MPSYY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
    Capital Cube3 months ago

    MorphoSys AG :MPSYY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016

    Click here to see latest analysisMorphoSys AG reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of MorphoSys AG – Merck & Co., Inc., Quest Diagnostics Incorporated, Johnson & Johnson, Novartis AG Sponsored ADR, PDL BioPharma, Inc., Rockwell Collins, Inc., STADA Arzneimittel AG Unsponsored ADR, Evotec […] (Read more...) The post MorphoSys AG :MPSYY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 appeared first on CapitalCube.

  • MorphoSys AG :MPSYY-US: Earnings Analysis: 2015 By the Numbers
    Capital Cube5 months ago

    MorphoSys AG :MPSYY-US: Earnings Analysis: 2015 By the Numbers

    Click here to see latest analysisMorphoSys AG reports financial results for the year ended December 31, 2015.HighlightsChange in operating cash flow of -29.54% compared to same period last year is about the same as change in earnings, likely no significant movement in accruals or reserves.Earnings decline largely a result of non-operational activity, pretax margins improved […] (Read more...) The post MorphoSys AG :MPSYY-US: Earnings Analysis: 2015 By the Numbers appeared first on CapitalCube.